Skip to Main Content

Paper Details

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.
Drug Metab Dispos
2
2022
Author NameAffiliation
Pablo Avil??sC.C.) and Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute
Rubin LubomirovC.C.) and Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute
Salvador FudioC.C.) and Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute
  • 1 - 3

Datasets

Release 1.2